Tian‐Huei Chu
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
- Biotechnology top 10%
- Cancer Research and Treatments 4
- Hepatology top 10%
- Liver physiology and pathology 5
-
- Fibroblast Growth Factor Research 5
- Angiogenesis and VEGF in Cancer 3
- Glycosylation and Glycoproteins Research 2
-
- Cancer Cells and Metastasis 4
-
- Renal cell carcinoma treatment 2
- Co-authors
- Ming‐Hong TaiMei‐Lang KungShih‐Chung HuangChao‐Cheng HuangTsung‐Hui HuShih‐Tsung HuangJian‐Ching WuZhi‐Hong Wen
- Partner nations
- TaiwanUnited StatesMalaysia
In The Last Decade
Tian‐Huei Chu
37 papers receiving 767 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 172
- Biotechnology 59
- Hepatology 54
- Molecular Biology 348
- Oncology 132
Countries citing papers authored by Tian‐Huei Chu
This map shows the geographic impact of Tian‐Huei Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian‐Huei Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian‐Huei Chu more than expected).
Fields of papers citing papers by Tian‐Huei Chu
This network shows the impact of papers produced by Tian‐Huei Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian‐Huei Chu. The network helps show where Tian‐Huei Chu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tian‐Huei Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 25 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 1 | |
| 15 | 2019 | 35 | |
| 16 | 2019 | 34 | |
| 17 | 2018 | 31 | |
| 18 | 2015 | 16 | |
| 19 | 2014 | 67 | |
| 20 | 2010 | 23 |
About Tian‐Huei Chu
Tian‐Huei Chu is a scholar working on Hepatology, Biotechnology and Cancer Research, having authored 41 papers that have together received 774 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (5 papers), Liver physiology and pathology (5 papers), Cancer Cells and Metastasis (4 papers), Cancer Research and Treatments (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Cancer Research (172 citations), Biotechnology (59 citations) and Hepatology (54 citations). Tian‐Huei Chu has collaborated with scholars based in Taiwan, United States and Malaysia. Frequent co-authors include Ming‐Hong Tai, Mei‐Lang Kung, Shih‐Chung Huang, Chao‐Cheng Huang, Tsung‐Hui Hu, Shih‐Tsung Huang, Jian‐Ching Wu, Zhi‐Hong Wen, Hoi‐Hung Chan and Deng‐Chyang Wu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.